Phase II trial of bevacizumab (B) plus everolimus (E) for refractory metastatic colorectal cancer (mCRC).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Altomare, I; Russell, KB; Uronis, HE; Morse, M; Hsu, SD; Zafar, Y; Bendell, JC; Starodub, A; Honeycutt, W; Hurwitz, H

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 3535 - 3535

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.3535